Prostate | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

published 3 months ago by Dr Neil Love

Faculty presentations from a CME symposium held at the 2019 Genitourinary Cancers Symposium. Featuring perspectives from Drs Emmanuel S Antonarakis, A Oliver Sartor, Howard I Scher, Matthew R Smith and Cora N Sternberg: Incorporation of Androgen Receptor Antagonists into the Management of M0 Prostate Cancer (PC) — Dr Smith (00:00) Management of Metastatic Hormone-Sensitive PC — Dr Sternberg (05:12) Current and Future Management of Metastatic Castration-Resistant PC — Dr Scher (16:06) Biologic Rationale for and Ongoing Evaluation of PARP Inhibitors in the Management of Metastatic PC — Dr Antonarakis (26:04) Bone-Targeted Therapies and Other Emerging Radiopharmaceuticals — Dr Sartor (37:06) Select publications  

more episodes from Research To Practice | Oncology Videos